Skip to content

Drug interactions

Fosaprepitant + Tofacitinib

Severity: Minor

Fosaprepitant and Tofacitinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosaprepitant is converted to aprepitant, a moderate CYP3A4 inhibitor, which may modestly raise tofacitinib levels. Exposure with a single short course is limited, so the effect is usually small.

What this interaction means in plain words

Fosaprepitant and Tofacitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fosaprepitant belongs to Gastrointestinal Tract; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Aprepitant inhibits CYP3A4, reducing tofacitinib metabolism.

What to do

No dose adjustment is usually needed; monitor for adverse effects such as infection or cytopenias if repeated dosing is used.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosaprepitant and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosaprepitant with Tofacitinib?

MediHelp rates the interaction as minor. Fosaprepitant and Tofacitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fosaprepitant is converted to aprepitant, a moderate CYP3A4 inhibitor, which may modestly raise tofacitinib levels. Exposure with a single short course is limited, so the effect is usually small.

How serious is the interaction between Fosaprepitant and Tofacitinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is usually needed; monitor for adverse effects such as infection or cytopenias if repeated dosing is used.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in